Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05172700
Title Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Loxo Oncology, Inc.
Age Groups: adult | senior
Covered Countries

No variant requirements are available.